Germany's hidden crisis: Teens like Philipp trapped by post-viral fatigue

Germany's hidden crisis: Teens like Philipp trapped by post-viral fatigue

A diagram of a human body with "Symptoms of Covid-19" written on the left side, illustrating symptoms like coughing, sneezing, and fatigue, along with text describing causes, symptoms, and treatments of the virus.

Germany's hidden crisis: Teens like Philipp trapped by post-viral fatigue

A growing number of people in Germany are facing long-term illness after viral infections. One of them is 14-year-old Philipp Damerau from Minden, who developed ME/CFS following a family trip. The condition, often triggered by viruses like COVID-19, Epstein-Barr, or influenza, leaves patients with severe fatigue and widespread bodily dysfunction.

Philipp Damerau fell ill two weeks after returning from the U.S. His diagnosis came later: myalgic encephalomyelitis, or chronic fatigue syndrome (ME/CFS). The condition disrupts the immune system, nervous system, energy production, and circulation. Symptoms include crushing fatigue, muscle pain, sleep problems, brain fog, and worsening exhaustion after even minor exertion.

ME/CFS is notoriously hard to diagnose. No specific lab test or biomarker exists, leading to long delays in treatment. Many patients report being dismissed by doctors before receiving proper care. Therapy currently focuses on managing symptoms, as no cure exists. Pacing—carefully balancing activity and rest—remains the primary coping strategy.

The first COVID-19 case in North Rhine-Westphalia was confirmed on Shrove Tuesday in 2020. Since then, Germany has recorded around 40 million infections. Many still struggle with lasting effects, including ME/CFS. Estimates from December 2024 suggest 650,000 people in Germany live with post-viral ME/CFS, though exact numbers remain unclear. Severe cases often go uncounted, as those too ill cannot participate in surveys. Over a million more suffer from persistent symptoms like Long COVID.

The overlap between ME/CFS and Long COVID complicates tracking. Both conditions share similar features, making it difficult to distinguish between them. Without better diagnostic tools, patients face ongoing uncertainty and limited support.

ME/CFS affects hundreds of thousands in Germany, yet many remain undiagnosed or misunderstood. With no approved treatment, patients rely on symptom management while researchers seek clearer answers. The long-term impact of post-viral illnesses continues to shape public health challenges across the country.

Neueste Nachrichten